Advanced Enzyme Technologies Limited (ADVENZYMES) — FY26 Annual Report | 8 July 2026(2 announcements)
Advanced Enzyme Technologies announced that shareholders without registered email addresses will receive a link and QR code to access the Integrated Annual Report for FY 2025-26 and the notice for its 37th Annual General Meeting scheduled for July 31, 2026, via video conference, as required under SEBI Regulation 36(1)(b).
Advanced Enzyme Technologies Limited announced its 37th Annual General Meeting on July 31, 2026, via video conference, to transact ordinary and special business including approval of audited standalone and consolidated financial statements for FY2025-26, final dividend of ₹1.35 per share, reappointment of directors Mukund Kabra and Pradip Shah, reappointment of statutory auditors MSKA & Associates LLP for a second 5-year term, and approval of material related party transactions with JC Biotech Private Limited. The meeting will be conducted electronically with remote e-voting facilities provided through NSDL, and shareholders must update KYC details to receive dividends electronically.
About Advanced Enzyme Technologies Limited (ADVENZYMES)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when ADVENZYMES files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track ADVENZYMES — Free💡 Ask AI about this filing
📊 More ADVENZYMES filings
- share transfer — 14 July 2026 Advanced Enzyme Technologies Limited received a SEBI-mandated share transfer agent certificate for t...
- 🔴 Corporate Action — 3 July 2026 Advanced Enzyme Technologies Limited announced that its 37th Annual General Meeting will be held on ...
- 🟡 Board Meeting — 3 July 2026 Advanced Enzyme Technologies Limited announced that its 37th Annual General Meeting will be held on ...
- Financial Results — 25 June 2026 Advanced Enzyme Technologies Limited announced that its trading window will close on July 1, 2026, a...
- regulation 31 — 12 June 2026 Advanced Enzyme Technologies Limited disclosed under SEBI Takeover Regulations that promoter Chandra...
🔥 Also filed on 8 July 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when ADVENZYMES files new disclosures
Track ADVENZYMES filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track ADVENZYMES — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research